Partnership activities and how they address needs and challenges

H3D is the first and only centre of its kind on the African continent. It is a place where African scientists can utilize their scientific skills and education to improve the health of African patients and to educate the next generation of African pharmaceutical scientists.

H3D is uniquely positioned to seed the establishment of an innovative pharmaceutical industry in Africa. One of the key strengths of the Centre is its neutral positioning, which allows for strong partnerships with governments, philanthropies, industry, and academic partners, forming a bridge between academic and translational science.

H3D has four drug discovery portfolios (malaria, TB, AMR, and COVID-19) that are largely funded through research grants with a programmatic focus. H3D relies on an extensive international network of partners and collaborators to bring in relevant expertise and capacities to assist with sustaining the portfolio pipelines and delivering preclinical candidates. Product development and industry partners are particularly positioned to take any preclinical candidates emerging from the Centre through development.